Cargando…
Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis
BACKGROUND: The presence of myocardial fibrosis by cardiac MRI has prognostic value in cardiac sarcoidosis, and localisation may be equally relevant to clinical outcomes. OBJECTIVE: We aimed to analyse cardiac damage and function in detail and explore the relationship with clinical outcomes in patie...
Autores principales: | Yasuda, Masakazu, Iwanaga, Yoshitaka, Kato, Takao, Izumi, Toshiaki, Inuzuka, Yasutaka, Nakamura, Takashi, Miyaji, Yuki, Kawamura, Takayuki, Ikeguchi, Shigeru, Inoko, Moriaki, Kurita, Takashi, Miyazaki, Shunichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975863/ https://www.ncbi.nlm.nih.gov/pubmed/27547432 http://dx.doi.org/10.1136/openhrt-2016-000437 |
Ejemplares similares
-
T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis
por: Tonegawa-Kuji, Reina, et al.
Publicado: (2021) -
Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes
por: Seko, Yuta, et al.
Publicado: (2021) -
Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018) -
Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019) -
Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)